Farther Finance Advisors, LLC
Position in IMDX — Insight Molecular Diagnostics Inc.
CIK 1992825
SAN FRANCISCO, CA
Position in IMDX
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$5
+$2 QoQ
Shares Held
1
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 40 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IMDX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Farther Finance Advisors, LLC holds $24,371,669 across 33 Diagnostics & Research names. IMDX ranks #31 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
13,098 | $6,566,813 | |
| 2 | DHR |
Danaher Corp /De/
|
18,623 | $3,547,309 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
15,100 | $2,917,622 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
3,871 | $2,037,849 | |
| 5 | ICLR |
Icon PLC
|
10,374 | $1,802,067 | |
| 6 | DGX |
Quest Diagnostics Inc
|
8,362 | $1,772,325 | |
| 7 | LH |
Labcorp Holdings Inc.
|
3,445 | $964,600 | |
| 8 | A |
Agilent Technologies, Inc.
|
5,694 | $756,334 |
All Filings in IMDX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5 | 1 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $3 | 1 | Shares | Sole | 2026-04-07 | |
| No filing history on record for this holder in this stock. | ||||||